- Home
- CRIS vs FEAM Comparison
CRIS vs FEAM Comparison
Compare CRIS & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- FEAM
- Stock Information
- Founded
- CRIS 2000
- FEAM 2016
- Country
- CRIS United States
- FEAM United States
- Employees
- CRIS N/A
- FEAM N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- FEAM Major Chemicals
- Sector
- CRIS Health Care
- FEAM Industrials
- Exchange
- CRIS Nasdaq
- FEAM Nasdaq
- Market Cap
- CRIS 32.8M
- FEAM 12.8M
- IPO Year
- CRIS 2000
- FEAM N/A
- Fundamental
- Price
- CRIS $2.84
- FEAM $3.15
- Analyst Decision
- CRIS Strong Buy
- FEAM Strong Buy
- Analyst Count
- CRIS 3
- FEAM 2
- Target Price
- CRIS $23.00
- FEAM $121.00
- AVG Volume (30 Days)
- CRIS 28.2K
- FEAM 33.7K
- Earning Date
- CRIS 05-06-2025
- FEAM 04-28-2025
- Dividend Yield
- CRIS N/A
- FEAM N/A
- EPS Growth
- CRIS N/A
- FEAM N/A
- EPS
- CRIS N/A
- FEAM N/A
- Revenue
- CRIS $10,259,000.00
- FEAM N/A
- Revenue This Year
- CRIS N/A
- FEAM N/A
- Revenue Next Year
- CRIS N/A
- FEAM N/A
- P/E Ratio
- CRIS N/A
- FEAM N/A
- Revenue Growth
- CRIS 0.44
- FEAM N/A
- 52 Week Low
- CRIS $2.57
- FEAM $2.82
- 52 Week High
- CRIS $17.49
- FEAM $45.89
- Technical
- Relative Strength Index (RSI)
- CRIS 41.65
- FEAM 28.61
- Support Level
- CRIS $2.57
- FEAM $2.82
- Resistance Level
- CRIS $3.15
- FEAM $3.74
- Average True Range (ATR)
- CRIS 0.17
- FEAM 0.70
- MACD
- CRIS -0.02
- FEAM 0.09
- Stochastic Oscillator
- CRIS 44.26
- FEAM 12.44
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.